ACTINIUM PHARMACEUTICALS, INC. Professional Fees
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Professional Fees of $13.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2012-11-14
- ACTINIUM PHARMACEUTICALS, INC. professional fees for the quarter ending 2012-09-30 was $2.04K, a 16.05% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. professional fees for the quarter ending 2012-06-30 was $3.55K.
- ACTINIUM PHARMACEUTICALS, INC. professional fees for the quarter ending 2012-03-31 was $7.41K.
- ACTINIUM PHARMACEUTICALS, INC. professional fees for the quarter ending 2011-12-31 was $2.48K, a 65.79% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. professional fees for fiscal 2011 was $9.62K, a 62.15% decline from fiscal 2010.
- ACTINIUM PHARMACEUTICALS, INC. professional fees for fiscal 2010 was $25.41K.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month |
|---|---|---|---|---|
| 2012-09-30 | $2.04K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $5.59K derived: sum of 2 quarters · filed 2012-11-14 | $13.00K 10-Q · filed 2012-11-14 | $15.47K derived: sum of 4 quarters · filed 2012-11-14 |
| 2012-06-30 | $3.55K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | $10.96K 10-Q/A · filed 2012-08-29 | $13.44K derived: sum of 3 quarters · filed 2012-08-29 | $15.87K derived: sum of 4 quarters · filed 2012-11-14 |
| 2012-03-31 | $7.41K 10-Q · filed 2012-04-23 | $9.88K derived: sum of 2 quarters · filed 2012-04-23 | $12.31K derived: sum of 3 quarters · filed 2012-11-14 | |
| 2011-12-31 | $2.48K 10-Q · filed 2012-04-23 | $4.91K derived: sum of 2 quarters · filed 2012-11-14 | $9.62K 10-K · filed 2012-04-12 | |
| 2011-09-30 | $2.43K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $8.14K 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | $5.71K 10-Q/A · filed 2012-08-29 | |||
| 2010-12-31 | $7.24K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-12 | $15.21K derived: sum of 2 quarters · filed 2012-04-12 | $25.41K 10-K · filed 2012-04-12 | |
| 2010-09-30 | $7.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $18.17K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $10.19K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |